Your shopping cart


Total (VAT incl.)

VAT (21%)
You have not added any reports to the cart yet.
Request reports
If you prefer to place your order via e-mail
contact us at: digital@azierta.com

Events and news

Home > Blog > Toxicology

Azierta completes the webinar ''Nitrosamine impurities: present, past and future'' with a great reception from the audience

The webinar discussed the essential aspects of nitrosamines impurities, which can be carcinogenic and require manufacturers to evaluate their products.

This Tuesday 27th October Azierta organized a professional webinar on nitrosamines impurities with 231 attendees. Ana Maria Castro, Industrial Area Manager, and Javier Fernandez, Senior Toxicology Officer, presented the content in two different blocks with special attention to the control and surveillance strategy.

The purpose of this webinar, which was developed online, is to provide guidance on how Marketing Authorisation Holders (MAHs) should conduct a proper analysis of products at risk of containing nitrosamines impurities, which could lead manufacturers to change the manufacturing process. The FDA and the EMA are providing MAHs with guidance on how to comply with this measure after it has been demonstrated that nitrosamines impurities can be carcinogenic.

New deadlines have been agreed for mandatory risk assessment, 31 March 2021 for chemical medicines and 1 July 2021 for biological medicines.

Azierta has a professional and multidisciplinary team of experts with great experience in the implementation of ICH Q9 quality management regulations and in the evaluation and control of mutagenic impurities according to ICH M7. It also has a specialised toxicological support area accredited by AETOX, EUROTOX and ERT.

Azierta is a consultancy firm specialised in Science and Health that is committed to promoting the relationship between science and the business environment through the "Science to Business" concept.




Related posts

Polymeric materials in manufacturing processes: a new theat...

In the last few years, elastomer, thermoplastic or thermostable plastic polymeric materials have become established as basic...

Read more

Interview with Paulino Alonso: ICHQ3D on Elemental impurities...

ICHQ3D implementation involves a risk analysis to design strategies to control elemental impurities in drugs for human use,...

Read more

Leading innovation in pharma & health

100 professionals

Over 100 professionals

500 clients

Over 500 clients

9 year experience

9 years of experience


Leading innovation

Client oriented

100% client oriented

We are at your complete disposal for any inquiry

Thank you for getting in touch! We will contact you as soon as possible to help you out
There has been an error while submitting your form, please try again, or call us at 912 77 10 76
Schedule appointment

Schedule a video call with our field experts

We use "cookies" to improve your experience on our site. Cookies enable us to tailor messages and display ads to your interests. They also help us understand how our site is being used. By continuing to use our site you consent to use our cookies.